Form 4: Arteris Director Wayne C. Cantwell Executes Stock Sales Under 10b5-1 Plan
SEC Form 4
Wayne C. Cantwell, a director at Arteris, Inc., sold 10,000 shares of common stock over two days under a pre-arranged 10b5-1 trading plan.
Summary
- Wayne C. Cantwell, a director of Arteris, Inc., reported the sale of 10,000 shares of common stock.
- The sales occurred on January 2, 2025, and January 3, 2025.
- These transactions were executed under a 10b5-1 trading plan adopted on June 7, 2024.
- On January 2, 2025, 5,000 shares were sold at a weighted average price of $11.0058 per share.
- On January 3, 2025, 5,000 shares were sold at $12.08 per share.
- Following these transactions, Cantwell directly owns 228,198 shares and indirectly owns 38,761 shares through a 401K plan.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock sales under a pre-arranged plan, so it has a neutral sentiment.
Industry Context
Sales by company directors are a normal part of corporate governance. The use of a 10b5-1 trading plan allows insiders to sell shares without being accused of acting on non-public information.
Stakeholder Impact
- The stock sales may have a minor impact on shareholders due to the increased supply of shares in the market.
Key Dates
| Date | Description |
|---|---|
| June 7, 2024 | Date the Reporting Person adopted the 10b5-1 trading plan |
| January 2, 2025 | Date of first reported stock sale |
| January 3, 2025 | Date of second reported stock sale |
| January 6, 2025 | Date of report filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.